Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Antagonistic (one drug reduces the effect of another)
Nausea typically peaks during dose escalation and often improves with time at stable doses
In that case, skip the missed dose and continue your regular schedule
A comprehensive meta-analysis published in 2022 examining data from randomized controlled trials involving GLP-1 receptor agonists found no statistically significant increase in overall cancer incidence
Side Effects and Safety Profile Like other GLP-1based therapies, Retatrutides side effects are largely gastrointestinal and dose-dependent but overall, it has shown a favorable safety profile in clinical trials so far
